Lumen Bioscience is pioneering a transformative approach to the development of biologic drugs, leveraging a patented technology that utilizes engineered spirulina as a production platform. This innovative method allows for the rapid and cost-effective manufacturing of biologics, enabling the creation of therapeutics that can be delivered orally. By introducing therapeutic genes into spirulina, the organism can produce high quantities of proteins, which are then harvested and processed into shelf-stable capsules. This process not only significantly reduces the cost of biologic drug production—by two to three orders of magnitude compared to traditional methods—but also enhances the accessibility of these treatments for a broader patient population.

The company is focused on addressing significant unmet medical needs across various diseases, including C. difficile, COVID-19, inflammatory bowel disease (IBD), and metabolic diseases. Lumen's biologics are designed to target specific disease mechanisms, such as neutralizing pathogens or modulating metabolic signaling, with an emphasis on safety and effectiveness. The ability to produce high-dose biologics that are stable at room temperature and can be taken orally represents a major advancement in drug delivery, particularly for populations in low-resource settings. By prioritizing the development of affordable and accessible treatments, Lumen aims to make a substantial impact on global health challenges.

United States

Lumen Bio is a clinical-stage biotechnology company developing topically and mucosally delivered biologic drugs to treat and prevent highly prevalent diseases.

Cardiovascular Diseases

Digestive System Diseases

Infectious Diseases

Lumen Bioscience

Clostridioides difficile infection

Lumen Product Candidate #1

Biologics

COVID-19

Lumen Product Candidate #2

Antibodies

Crohns disease

Ulcerative colitis

Lumen Product Candidate #3

Cardiometabolic Disease

Lumen Product Candidate #4

Washington

Microbiome

Protein Therapies

Therapeutic

Lumen Bioscience

Company Details